Fig. 12 | Scientific Reports

Fig. 12

From: Cilazapril and benazepril mitigate neurodegeneration and α-synuclein accumulation in a cellular model of parkinson’s disease

Fig. 12The alternative text for this image may have been generated using AI.

Effects of cilazapril and benazepril on the 6-OHDA-induced increase in IL-10 levels. (a) Cilazapril reversed the 6-OHDA-induced decrease in IL-10 levels to a moderate extent in a dose-dependent manner. The C-1.28 and C-5.12 groups showed significant improvement (*p < 0.05). (b) Benazepril significantly restored the IL-10 levels, particularly in the B-0.08 and B-0.16 groups. This resulted in values closer to those of the control group (*p < 0.05).

Back to article page